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ABSTRACT 
Tumor necrosis factor-alpha (TNF-α) is best-known as a potent pro-inflammatory cytokine involved in many 
cardiovascular diseases. During vascular calcification, TNF-α has been reported topromote osteogenic differentiation of 
human vascular smooth muscle cells (VSMC) and mesenchymal stem cells (MSCs). In contrast, there is alack of data 
reporting the osteoinductive effect of TNF-α in endothelial cell. In this study, experiments were performed to investigate 
and determine theoptimum dose of TNF-α that induces expression of the osteoinductive factor bone morphogenetic protein 
(BMP-2) in endothelial cells. Human vein endothelial cells were treated with TNF-α at doses of 0, 2, 5, 10, or 20 ng/mL 
for2, 8, or 24 h time intervals. BMP-2 cell expression was evaluated using immunocytochemistry staining by calculating 
the percentage of BMP-2 positive cells. Apoptosiswas determined by counting the number ofpyknoticcells. In this study, 
we found that the optimum dose of TNF-α thatinduces BMP-2 expression in endothelial cells was 5 ng/mL at the 8 h time 
interval. Lower (2 ng/mL) orhigher (10 and 20 ng/mL) concentrations of TNF-α had minimal effects on BMP-2 expression. 
Moreover, higher concentrations of TNF-α treatment (10 and 20 ng/ml) at8 h and 24 h increased the presence of pyknotic 
endothelial cells, which representthefinal stage of apoptosis.  
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INTRODUCTION 
TNF-α is best-known as a potent pro-inflammatory 
cytokine. As a pleiotropic cytokine, TNF-α plays an 
important role in osteogenesis. Depending on the 
microenvironment, in ostial tissues such as bone, TNF-α 
accelerates osteoclast activity leading to bone resorption 
duringthefinal stages of osteoporosis1,2. In extra-ostial 
tissues, such as vascular tissue, TNF-α promotes mineral 
deposition leading to calcification3,4. Calcification leads to 
decreased vascular elasticity and increased vascular 
stiffness, whichcontribute tosystolic hypertension5,6. It has 
been widely reported that TNF-α promotes a shift toward 
osteogenic differentiation in human vascular smooth 
muscle cells (VSMCs)7. TNF-α plays a pivotal role in 
regulating the shift of vascular mesenchymal tissues 
toward anosteogenic phenotype8,9. Moreover, endothelial 
cells area primary target of TNF-α-induced organ damage 
leading to endothelial dysfunction and vascular 
calcification10. Some studies have reported that TNF-
alpha-exposed endothelial cells undergo osteogenic 
differentiation11,12. A shift toward an osteogenic phenotype 
causes endothelial cells to secrete bone morphogenetic 
protein 2 (BMP-2), which is a strong bone inductor of 
osteogenic activity inosteoblastsduringbone formation13. 
The role of TNF-α in VSMCs and mesenchymal stem cells 
(MSCs)is well documented, however the role of TNF-α in 
endothelial cells is less defined. It is poorly understood 
how TNF-α regulates endothelial BMP-2 expression. 
Hence, the aim of this study was to investigate TNF-α-
mediated regulation of BMP-2 expression in a dose- and 
time-dependent manner. 
 
MATERIALS AND METHODS 
This study obtained ethics approval by the Human Ethical 
Committee of the University of Brawijaya, Malang, 
Indonesia (141/EC/KEPK/S3/05/2016). Human umbilical 
vein endothelial cells (HUVECs) were isolated by 
digestionof umbilical cord veins using 0.05% collagenase 
(from Clostridium histolyticum, Worthington, Lakewood 
New Jersey, USA) for 15 min. The medium was then 
changed to remove blood components and non-adherent 
cells. Adherentcells were then platedon25 cm2 Falcon 
flasks in RPMI-1640 medium containing25 mM HEPES 
and L-glutamine, 100 U/ml penicillin, 100 mg/ml 
streptomycin, 10% heat-inactivated fetal calf serum (FCS), 
and 10% newborn calf serum (NBCS). Cells were then 
allowed to attach to thedishes for 3 h. When cells 
reachedconfluency, ECs were detached with 0.05%  
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Figure 1: Immunostaining of BMP-2 in control endothelial cultures shows no BMP-2 expression with 0 ng/ml TNF-α 
at durations of 2 h, 8 h, and 24 h, respectively (A, B, C). At 2 ng/ml concentration of TNF-α, immunostaining shows 
minimal expression (D, E) of BMP-2 at 24 h (F). Treatment with TNF-α 5 ng/ml (G, H, I) demonstrates optimal 
expression of BMP-2 immunostaining at 8 h. Furthermore, low expression of BMP-2 is shown along with cellular 
pyknosis at 10 ng/ml at all times, 2 h, 8 h, or 24 h, respectively (J, K, L) and 20 ng/ml at 2 h, 8 h, or 24 h, respectively 
(M, N, O) (P<0.05). Arrows point to pyknosis and nuclear karyorrhexis in apoptotic endothelial cells. (M=400x). 
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trypsine: 0.02% EDTA, and subcultured at a 1 : 3 ratio in 
the EC cell growth medium above containing, in addition, 
15 mg/ml endothelial cell growth supplement (Sigma 
Chemical Co., UK) and 50 U/ml heparin (Leo Laboratories 
Limited, UK). Cells were then culturedon 24-well plates 
(Falcon;BD Biosciences, New Jersey) in M199 medium 
containing20% feta bovine serum, 100 U/ml penicillin-
streptomycin, 0.1 mg/ml heparin, and 0.05 mg/ml EGF. 
Cells werethen incubated at 370C in a 5% CO2humidified 
incubator. At80% confluency, cells wereexposedto 
increasingdoses of TNF-α (0, 2, 5, 10, 20 ng/ml) for 2, 8, 
or 24 h intervals. Cells were fixed with5 %methanol and 
stainedwith BMP-2 antibodies. 
Statistical Analysis 
Data were analysed by one-way ANOVA and the 
differences between groups wereanalysed by LSD post hoc 
comparison tests. Data are expressed as mean±standard 
error of the mean (SEM). P values less than 0.05 were 
considered statistically significant. 
 
RESULTS AND DISCUSSION 
In this study, we show that TNF-α increases expression of 
BMP-2 in endothelial cells in a dose-and time-dependent 
manner. As shown in Fig 1, the optimal dose of TNF-α that 
induces BMP-2 is 5 ng/ml atthe 8 h time interval. TNF-α 
treatment does not increase BMP-2 expression at doses 
above this concentration because TNF-α at 10 and 20 
ng/ml induce cellular apoptosis, particularly at the 8 h time 
interval, as shown in Fig 3. BMP-2 is not optimally 
expressed at TNF-α 10 or 20 ng/ml, perhaps because 
cellular apoptotic signalling is activated before optimum 
BMP-2 signalling has been reached. As seen in area 
percentage in Fig 2, BMP-2 expression decreases and cells 
became more pyknotic, as shown in Fig 3.    
In Fig 3, the number of pyknotic cells increased in 
response to TNF-α at 10 or 20 ng/ml concentrations14. The 
induction of pyknosis can be explained due to activation of 
either the TRAF pathway or the endoplasmic reticulum 
pathway15. Low doses of TNF-α at 2 ng/ml results in lower 
BMP-2 expression at 2 h, 8 h, and 24 h time points. 
However, different results were obtained by Buendia et al. 
who used 20 nm/ml of TNF-α with 24 h duration to induce 
endothelial secretion of micro-particles. It is debatable as 
to whether micro-particle secretion can induce in false 
positive results due to apoptotic cellular fragments or are a 
true function of exocytotic cellular vesicles16,17. 
Endothelial micro-particles are often misunderstood by 
many researchers as independent membrane vesicular cell 
 
Figure 2: BMP-2 expression optimally increase in TNF-α 5ng/ml at 8h and gradually decrease in higher dose at 10 
and 20 ng/ml. In control solution TNF-α 0 and 2 ng/ml shows minimally BMP-2 expression at any time interval 2h, 
8h and 24h (* p<0.05). 
 
Figure 3: TNF-α 10 and 20 nm/ml at any duration shows more  pycnotic cells compare than TNF-α 0, 2 and 5 ng/ml 
(p<0.05). 
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products. In addition, many reportshaveconcluded that 
microparticles areactually apoptotic bodies that are 
released during the final stages of cellular apoptosis18.  
 
CONCLUSIONS 
The optimum dose of TNF-α that induces BMP-2 
expression in endothelial cells without inducing apoptosis 
is a moderate dose of 5 ng/mL at the 8 h time interval. The 
lower (2 ng/mL) or higher (10 and 20 ng/mL) 
concentrations of TNF-α resulted in minimal expression of 
BMP-2. Moreover, higher concentrations of TNF-α (10 
and 20 ng/ml) at 8 h or 24 h time intervals induced 
apoptosis in endothelial cells. These data maybe useful for 
further studies that examine TNF-α-induced expression of 
BMP-2 in endothelial cells. 
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